1. Home
  2. LOPE vs AMRX Comparison

LOPE vs AMRX Comparison

Compare LOPE & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LOPE

Grand Canyon Education Inc.

HOLD

Current Price

$165.92

Market Cap

4.6B

Sector

Real Estate

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.57

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOPE
AMRX
Founded
1949
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.8B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
LOPE
AMRX
Price
$165.92
$12.57
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$220.00
$13.25
AVG Volume (30 Days)
436.1K
2.0M
Earning Date
11-05-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
7.46
0.02
Revenue
$1,090,524,000.00
$2,934,959,000.00
Revenue This Year
$9.20
$9.99
Revenue Next Year
$6.83
$6.67
P/E Ratio
$22.24
$669.75
Revenue Growth
7.05
9.50
52 Week Low
$149.83
$6.69
52 Week High
$223.04
$12.82

Technical Indicators

Market Signals
Indicator
LOPE
AMRX
Relative Strength Index (RSI) 52.85 62.29
Support Level $158.98 $12.14
Resistance Level $158.67 $12.53
Average True Range (ATR) 4.43 0.33
MACD 2.84 -0.01
Stochastic Oscillator 92.47 80.18

Price Performance

Historical Comparison
LOPE
AMRX

About LOPE Grand Canyon Education Inc.

Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges both online, on the ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: